Archive
Past newsletters of MDDR.
Past newsletters of MDDR.
Past newsletters of MDDR.
Tuesday, 27 October 2026
Following last month’s coverage of Tasmania’s pharmacist UTI service, the Federal Government has expanded its planned 12-month pharmacy pres
Monday, 26 October 2026
Mitapivat, an oral pyruvate kinase activator, has been investigated as a potential disease-modifying treatment for people with sickle cell d
Saturday, 24 October 2026
Payments to practices and GPs under the Bulk Billing Practice Incentive Payment program reached $192.3 million in its first eight months, ac
Friday, 23 October 2026
Following recent pharmacy access reforms, the TGA has now approved MS-2 Step for medical abortion up to 70 days’ gestation and for medical m
Thursday, 22 October 2026
The PBAC has recommended broader PBS access to atomoxetine and guanfacine and expanding authorised prescribers beyond specialists for treatm
Wednesday, 21 October 2026
The updated Australian cardiovascular disease risk calculator classified 26.4% of people as having intermediate five-year risk, more than do
Tuesday, 20 October 2026
The PBAC has recommended adding nirsevimab to the National Immunisation Program for babies and children up to two years of age to protect ag
Monday, 19 October 2026
Karl Deisseroth, Peter Hegemann and Georg Nagel were awarded the 2026 Nobel Prize in Physiology or Medicine. The source gives no details abo
Sunday, 18 October 2026
Edwards Lifesciences has asked customers to remove and return four lots of Commander M delivery systems used for Sapien M3 transcatheter mit
Saturday, 17 October 2026
Eight of 12 digital scribe products reviewed by the TGA had functions likely to meet the legal definition of a medical device, although none